Effects of aging and the body mass index on male sex hormones: a cross-sectional study in 701 Brazilian men
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2022.186112Keywords:
Male aging, Sex hormone binding globulin, Pituitary luteinizing hormone, HypogonadismAbstract
Background: Some studies indicated that body mass index (BMI) is inversely proportional to serum testosterone concentrations in men.
Purposes: This study aimed to analyze the effects of aging and obesity on total testosterone (TT), free testosterone (FT), bioavailable testosterone (BT), luteinizing hormone (LH), and sex hormone-binding globulin (SHBG) levels.
Methods: A cross-sectional study was performed to assess the clinical and laboratory profiles of 701 patients treated at a private urology clinic in Ponta Grossa, Brazil, from January 2016 to December 2018.
Results: Patients’ age ranged from 16 to 88 years (mean, 56.9 ± 13.62 years). Age did not significantly influence serum TT concentrations, except compared to patients aged >70 years. However, changes were observed in FT and BT (p < 0.05). The mean SHBG increased with age (p < 0.05). A tendency toward LH elevation was observed in older patients, but it was not statistically significant. An inverse proportional relationship between TT, FT, and BT and the testosterone deficiency rate (TT < 300 ng/dL) was observed within BMI groups (p < 0.05). The testosterone deficiency rate was 21.5% in individuals with normal BMI, 29% in overweight individuals, and 37% in obese individuals.
Conclusions: Aging affected the testosterone concentrations in men and became increasingly evident using FT and BT instead of TT. SHBG increased with age. Obesity was associated with a decrease in TT, FT, and BT but also increased the rate of hypogonadism.
Downloads
References
American Urological Association (AUA): Evaluation and Management of Testosterone Deficiency AUA guideline. Avaliable in <https://www.auanet.org/guidelines/testosterone-deficiency-guideline>. Accessed in September, 2020.
Barbonetti A, D'Andrea S, Francavilla S: Testosterone replacement therapy. Andrology. 2020; 0:1–16.
Hammond GL, Wu TS, Simard M: Evolving utility of sex hormone-binding globulin measurements in clinical medicine. Curr Opin Endocrinol Diabetes Obes. 2012; 19(3):183-189.
Golan R, Scovell JM, Ramasamy R: Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function. Aging Male. 2015; 18(3):201-204.
DeFina LF, Radfordb NB, Leonarda B, Wilsonb RK, Cooperb TC, Clarkb SM, et al: The association of cardiorespiratory fitness, body mass index, and age with testosterone levels at screening of healthy men undergoing preventive medical examinations: The Cooper Center Longitudinal Study. Maturitas. 2018; 118:1–6.
Kelly DM, Jones TH. Testosterone and obesity. Obesity Reviews. 2015;16(7):581-606.
Traish AM: Testosterone and weight loss: the evidence. Cur Opinion Endocrinol Diabetes Obesity. 2014;21(5):313–322.
Chiles KA: Hypogonadism and erectile dysfunction as harbingers of systemic disease. Transl Androl Urol. 2016;5(2):1954.
Vidigal DJA, Vidigal FEC, Rocha MVC: Correlação da Testosterona Total com a Idade, PSA e Peso da Próstata. Rev Urominas 2016; 36(34):25-28.
Fiers T, Kaufman JM. Free & Bioavailable Testosterone calculator. Avaliable in <http://www.issam.ch/freetesto.htm>. Acesso em setembro de 2019.
World Health Organization: Obesity: preventing and managing the global epidemic. Report of a World Health Organization Consultation. Geneva: World Health Organization;2000. 253 p.
Fabbri E, An Y, Gonzalez-Freire M, Zoli M, Maggio M, Studenski S, et al: Bioavailable Testosterone Linearly Declines Over A Wide Age Spectrum in Men and Women From The Baltimore Longitudinal Study of Aging. J Gerontol A Biol Sci Med Sci. 2016;71 (9):1202–1209.
Deutschbein T, Mann K, Petersenn S: Total Testosterone and Calculated Estimates for Free and Bioavailable Testosterone: Influence of Age and Body Mass Index and Establishment of Sex-Specific Reference Ranges. Horm Metab Res 2015;47:846–854.
Liu Z, Liu J, Shi X, Wang L, Yang Y, Tao M, Fu Q: Comparing calculated free testosterone with total testosterone for screening and diagnosing late-onset hypogonadism in aged males: A cross-sectional study. J Clin Lab Anal 2016; 1–7.
Mehta A, Bolyakov A, Sultan RC, Vaucher L, Mielnik A, Kiper J, Paduch DA: Testosterone Levels Do Not Decline with Age in Healthy Men. Open J Urol. 2013;3:173-178.
Surampudi P, Swerdloff RS, Wang C: An update on male hypogonadism therapy. Exp Opinion Pharmacotherapy 2014;15(9):1247–1264.
Halmenschlager G, Rhoden EL, Riedner CE: The influence of age on bioavailable and free testosterone is independent of body mass index and glucose levels. World J Urol 2011;29:541–546.
Samipoor F, Pakseresht S, Rezasoltani P, Mehrdad M: The association between hypogonadism symptoms with serum testosterone, FSH and LH in men. Aging Male 2018;21(1):1-8.
Camacho E, Huhtaniemi I, O'Neill T, Finn J, Pye S, Lee D, Tajar A, et al: Age-associated changes in hypothalamic–pituitary–testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol. 2020;168(3):445-455.
Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O’Neill TW, Huhtaniemi IT: Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93(7):2737-2745.
Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A, Dandona P: Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010;33(6):1186-1192.
Clifton S, Macdowall W, Copas AJ, Tanton C, Keevil BG, Lee DM, et al: Salivary Testosterone Levels and Health Status in Men and Women in the British General Population: Findings from the Third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). J Clin Endocrinol Metab. 2016;101(11):3939–3951.
Soriguer F, Rubio-Martı E, Fernandez D, Valde´s S, Garcıa-Escobar E, Martın-Nunez GM, Esteva I, Almaraz MC,Rojo-Martınez G: Testosterone, SHBG and risk of type 2 diabetes in the second evaluation of the Pizarra cohort study. Eur J Clin Invest. 2012; 42(1):79–85.
Eriksson J, Haring R, Grarup N, Vandenput L, Wallaschofski H, Lorentzen E, et al: Causal relationship between obesity and serum testosterone status in men: A bidirectional mendelian randomization analysis. PLoS One 2017;12(4):1-15.
Ahima RS: Adipose tissue as an endocrine organ. Obes. 2006;14(5):242-251.
Pelusi C, Pasquali R: The significance of low testosterone levels in obese men. Curr Obes Rep. 2012;1:181-190.
Corona G, Monami M, Saad F, Luconi M, Luchese M, Facchiano E, Storza A, Forti G, Mannucci E, Maggi M: Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168(6):829-843.
Maseroli E, Corona G, Giuaglli VA, Vignozzi L, Aversa A, Ziztmann M, Saad F, Mannucci E, Maggi M: Testosterone supplementation and body composition: results from a meta-analysis study. Eur J Endocrinol. 2015;4.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Bernardo Passos Sobreiro, Amanda Louise Bernardon dos Santos, Izabel Cristina Leinig Araujo, Lucas Felipe Karasinski, Rodrigo Jahn Soares, Renato Mitsunori Nisihara
This work is licensed under a Creative Commons Attribution 4.0 International License.
